Medical/Pharmaceuticals
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced interim data from a Phase II clinical trial of STP705, a siRNA (small interfering RNA) therapeutic, ...
2022-02-23 17:53
3801
Citadel Health: Pandemic highlights data revolution urgency
LONDON, Feb. 23, 2022 /PRNewswire/ -- David Wells, the biomedical scientist who spearheaded NHS England's COVID-19 testing response, says the pandemic's scale and impact highlights the urgent need to reshape diagnostics worldwide. Mr Wells led the NHS drive to build a nationwide testing service f...
2022-02-23 14:53
2299
The journey from Good to Great: Camly Academy successfully launched in the U.S market
HO CHI MINH CITY, Vietnam, Feb. 23, 2022 /PRNewswire/ -- Recently, Camly Academy of Camly Group successfully held an event to launch an educational platform in the US market with the topic: "Self-Education for Happiness: Good to Great" onFebruary 22, 2022 to announce action mission towards sustai...
2022-02-23 14:49
3049
Radiaction Opens First EU Radiation Protection Center of Excellence in Collaboration with Mazowiecki Hospital in Ostrołęka, Poland
TEL AVIV, Israel, Feb. 22, 2022 /PRNewswire/ -- Radiaction Medical Ltd
2022-02-23 10:00
3155
Havas Health & You Announces Expansion Across APAC, Including Southeast Asia (SEA) Village
SINGAPORE, Feb. 23, 2022 /PRNewswire/ -- In the next decade, APAC will represent 40% of total growth in global health spending, expanding at a rate almost double that of the rest of the world – making both presence and investment in APAC more critical than ever. To help Havas Health & You (HH&Y) ...
2022-02-23 09:00
2433
XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System
The XACT ACE® Robotic System addresses the limitations of traditional manual methods and other image-guided percutaneous intervention systems. SAN ANTONIO, Feb. 22, 2022 /PRNewswire/ -- Frost & Sullivan recently evaluated the North American percutaneous procedure system industry and, based on it...
2022-02-22 23:00
2557
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution
BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement withHiroshima University, one of the top public universities inHiroshima City, Japan, to support their molecular profiling by next-generation sequencing ...
2022-02-22 20:57
3327
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company
SEOUL, South Korea, Feb. 22, 2022 /PRNewswire/ -- RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest global pharmaceutical companies Eli Lilly and Company (hereinafter referred to as "Eli Lilly...
2022-02-22 20:52
4671
4D IMAGING RADAR LEADER VAYYAR EXPANDS GLOBAL FOOTPRINT WITH NEW JAPAN OFFICE
- Vayyar Imaging's new office will open in Tokyo, Japan in February, supporting the technology company's growth strategy in the key senior care and automotive markets - Vayyar's touchless senior care technology is deployed in facilities and private homes around the world, providing activity moni...
2022-02-22 17:00
3813
Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, Feb. 22, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification, effectiveJanuary 11, for NX-PHARMA Logistics Hub Kansai Airport, a temperature-controlled fa...
2022-02-22 15:00
3680
Nanoform 4Q and full year 2021 report: accelerating GMP growth
HELSINKI, Feb. 22, 2022 /PRNewswire/ -- The strong momentum continues: first two customer GMP projects signed, full-year gross margin exceeds 2025 target, the rapid growth in orders received and revenue recognized accelerates further, the first clear signs of economics of scale emerges, while the...
2022-02-22 14:33
2046
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...
2022-02-21 08:05
4099
VISTA Eye Specialists works with Tzu Chi Malaysia to Help Restore Eyesight with 100 Charity Cataract Surgery
PETALING JAYA, Malaysia, Feb. 21, 2022 /PRNewswire/ -- In conjunction with World Sight Day 2021, VISTA Eye Specialist (VISTA) is continuing to support the fight towards eliminating preventable blindness by pledging to provide 100 Charity Cataract surgeries via a joint community service project wi...
2022-02-21 08:00
3709
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345
SAN FRANCISCO and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2022-02-21 08:00
4313
Seegene Announces Q4 and Full-Year 2021 Financial Results
* Total sales of 2021 stood at KRW 1.37 trillion, a 22% increase YoY * Q4 Revenue of KRW 410 billion, up 34% QoQ * Operating profit held steady YoY at KRW 666.7 billion despite its tripled strategic investments in R&D * Seegene to make a strategic shift to a 'molecular diagnostics(MDx) plat...
2022-02-17 20:00
3076
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL
SHANGHAI and NEW YORK, Feb. 17, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery and development company, today announced that it has used its proprietary AI platform to nominate a preclinical candidate compound (PCC) for innova...
2022-02-17 16:30
3762
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders
Resolv ER™ may remedy leading causes of blindness in adults LAGUNA HILLS, Calif., Feb. 17, 2022 /PRNewswire/ -- Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company's investigational new drug (IND) application to c...
2022-02-17 12:14
3458
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) and RET-Altered Thyroid Cancers in Taiwan, China
SUZHOU, China, Feb. 17, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the Taiwan Food and Drug A...
2022-02-17 09:19
5466
Cambridge Nutranostics has developed a point-of-care OCCL test prototype for testing blood plasma oxygen to monitor pregnancy health
CAMBRIDGE, England, Feb. 17, 2022 /PRNewswire/ -- Cambridge Nutranostics Ltd
(CNL,http://www.occltest.com
2022-02-17 09:00
2545
Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, Feb. 17, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2022-02-17 08:00
5640
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 295 media titles]
2026-09-18 16:29Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 291 media titles]
2026-09-24 10:30
CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 291 media titles]
2026-09-22 18:37
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 277 media titles]
2026-09-23 09:00
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 275 media titles]
2026-09-21 08:00Most Read
COSRX Brings Its 5 Peptide Lip Collection to Ulta Beauty Stores Offline
2026-09-18 22:00
11732
Sea, Gardens, Lawns and Hearths: Life Abroad Across Noah's N+ Club Network
2026-09-18 23:04
8397
Carro secures strategic investment from Orico
2026-09-18 16:29
7717
